April 1, 2024 |

To set their Phase II clinical trial of a novel anti-cancer compound up for success, our client sought early multidisciplinary insights on current unmet needs, as well as feedback on their preclinical and early Phase I data and proposed protocol, from three parallel groups comprising oncologists, oncology nurses, and patients.
For each group, we executed three virtual touchpoints. For the oncologist and nurse groups, these included a mix of asynchronous and synchronous components; for the patient advisors, only asynchronous insight-gathering was used to respect their privacy and time.
This content was provided by Impetus Digital